{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:36Z","timestamp":1791583176852,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.prostaglandins.2020.106501","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T11:31:37Z","timestamp":1602329497000},"page":"106501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Enalapril improves obesity associated liver injury ameliorating systemic metabolic markers by modulating Angiotensin Converting Enzymes ACE\/ACE2 expression in high-fat feed mice"],"prefix":"10.1016","volume":"152","author":[{"given":"Daniel Silva","family":"Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah de Farias","family":"Lelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Marcus Oliveira","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz Sena","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Maur\u00edcio Batista","family":"De Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyana Concei\u00e7\u00e3o","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Henrique Sousa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January 13","key":"10.1016\/j.prostaglandins.2020.106501_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12967-015-0395-2","article-title":"Obesity is associated with a decrease in expression but not with the hypermethylation of thermogenesis-related genes in adipose tissues","volume":"27","author":"Kurylowicz","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prostaglandins.2020.106501_bib0010","series-title":"Prevalence of Overweight Among Adults, BMI \u2265 25, Crude, Estimates by World Bank Income Group [Internet]","year":"2018"},{"key":"10.1016\/j.prostaglandins.2020.106501_bib0015","series-title":"Overweight and Obesity; Defining Overweight and Obesity","author":"Prevention CoDCa","year":"2015"},{"issue":"January (3)","key":"10.1016\/j.prostaglandins.2020.106501_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"May (4)","key":"10.1016\/j.prostaglandins.2020.106501_bib0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","article-title":"The link between abdominal obesity, metabolic syndrome and cardiovascular disease","volume":"17","author":"Ritchie","year":"2007","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"January (2A)","key":"10.1016\/j.prostaglandins.2020.106501_bib0030","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"January 90","key":"10.1016\/j.prostaglandins.2020.106501_bib0035","first-page":"263","article-title":"Studies on the renin-angiotensin system in hypertensive patients","volume":"25","author":"Genest","year":"1964","journal-title":"Can. Med. Assoc. J."},{"issue":"May (5 Suppl)","key":"10.1016\/j.prostaglandins.2020.106501_bib0040","article-title":"Tissue renin-angiotensin systems. Their role in cardiovascular disease","volume":"87","author":"Lee","year":"1993","journal-title":"Circulation"},{"issue":"January (1 Pt 2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0045","article-title":"Localization and function of angiotensin AT1 receptors","volume":"13","author":"Allen","year":"2000","journal-title":"Am. J. Hypertens."},{"issue":"May (5)","key":"10.1016\/j.prostaglandins.2020.106501_bib0050","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/ATVBAHA.109.200493","article-title":"Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7)","volume":"30","author":"Santos","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"June (6 Pt 2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0055","first-page":"4","article-title":"Circulating versus local renin-angiotensin system in cardiovascular homeostasis","volume":"77","author":"Dzau","year":"1988","journal-title":"Circulation"},{"issue":"June (6)","key":"10.1016\/j.prostaglandins.2020.106501_bib0060","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1357-2725(02)00311-4","article-title":"The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?","volume":"35","author":"Engeli","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"December (12)","key":"10.1016\/j.prostaglandins.2020.106501_bib0065","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.tips.2011.07.006","article-title":"The renin-angiotensin-aldosterone system and glucose homeostasis","volume":"32","author":"Luther","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"July (5)","key":"10.1016\/j.prostaglandins.2020.106501_bib0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.physbeh.2010.03.018","article-title":"The renin angiotensin system and the metabolic syndrome","volume":"100","author":"de Kloet","year":"2010","journal-title":"Physiol. Behav."},{"issue":"MAY","key":"10.1016\/j.prostaglandins.2020.106501_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.peptides.2015.03.002","article-title":"Effect of enalapril maleate on ghrelin levels in metabolic syndrome in rats","volume":"67","author":"Aygen","year":"2015","journal-title":"Peptides"},{"issue":"March (5)","key":"10.1016\/j.prostaglandins.2020.106501_bib0080","article-title":"Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism","volume":"302","author":"Theken","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"June (3)","key":"10.1016\/j.prostaglandins.2020.106501_bib0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mam.2011.07.001","article-title":"Caloric restriction","volume":"32","author":"Speakman","year":"2011","journal-title":"Mol. Aspects Med."},{"issue":"May (3)","key":"10.1016\/j.prostaglandins.2020.106501_bib0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0148607112440285","article-title":"Consensus statement: academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition)","volume":"36","author":"White","year":"2012","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"issue":"July","key":"10.1016\/j.prostaglandins.2020.106501_bib0095","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00210-012-0774-7","article-title":"Effects of treatment with enalapril on hepatotoxicity induced by acetaminophen in mice","volume":"385","author":"Betto","year":"2012","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol."},{"issue":"July (7)","key":"10.1016\/j.prostaglandins.2020.106501_bib0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ultrasmedbio.2011.04.012","article-title":"High-frequency ultrasound imaging for longitudinal evaluation of non-alcoholic fatty liver disease progression in mice","volume":"37","author":"Fernandez-Dominguez","year":"2011","journal-title":"Ultrasound Med. Biol."},{"issue":"October (10)","key":"10.1016\/j.prostaglandins.2020.106501_bib0105","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.ultrasmedbio.2013.04.025","article-title":"Evaluation of ultrasound combined with chitosan for the control of weight and local fat in mice","volume":"39","author":"Liao","year":"2013","journal-title":"Ultrasound Med. Biol."},{"issue":"August (29)","key":"10.1016\/j.prostaglandins.2020.106501_bib0110","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.3748\/wjg.v18.i29.3889","article-title":"Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude","volume":"18","author":"Kuroda","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"October (37)","key":"10.1016\/j.prostaglandins.2020.106501_bib0115","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.3748\/wjg.v17.i37.4191","article-title":"Decreased accumulation of ultrasound contrast in the liver of nonalcoholic steatohepatitis rat model","volume":"17","author":"Miyata","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"February (2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/db07-0953","article-title":"Mas deficiency in FVB\/N mice produces marked changes in lipid and glycemic metabolism","volume":"57","author":"Santos","year":"2008","journal-title":"Diabetes."},{"key":"10.1016\/j.prostaglandins.2020.106501_bib0125","article-title":"RESOLU\u00c7\u00c3O N\u00ba 879, de 15 de Fevereiro de 2008","volume":"879","year":"2008","journal-title":"Stat."},{"issue":"June (6)","key":"10.1016\/j.prostaglandins.2020.106501_bib0130","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.HYP.35.6.1270","article-title":"Physiology and pathophysiology of the adipose tissue renin-angiotensin system","volume":"35","author":"Engeli","year":"2000","journal-title":"Hypertension."},{"issue":"December (14)","key":"10.1016\/j.prostaglandins.2020.106501_bib0135","first-page":"2727","article-title":"Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation","volume":"15","author":"Massiera","year":"2001","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology."},{"issue":"May (5)","key":"10.1016\/j.prostaglandins.2020.106501_bib0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00004872-199816050-00003","article-title":"Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators","volume":"16","author":"Cooper","year":"1998","journal-title":"J. Hypertens."},{"issue":"April (4)","key":"10.1016\/j.prostaglandins.2020.106501_bib0145","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1210\/endo.138.4.5038","article-title":"Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells","volume":"138","author":"Jones","year":"1997","journal-title":"Endocrinology."},{"issue":"June (6)","key":"10.1016\/j.prostaglandins.2020.106501_bib0150","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/jc.2003-032053","article-title":"Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects","volume":"89","author":"Goossens","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"February (1)","key":"10.1016\/j.prostaglandins.2020.106501_bib0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/138920309787315176","article-title":"Angiotensin II in type 2 diabetes mellitus","volume":"10","author":"Chu","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"issue":"September (1-2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1007133710837","article-title":"Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor","volume":"212","author":"Brasier","year":"2000","journal-title":"Mol. Cell. Biochem."},{"issue":"November (48)","key":"10.1016\/j.prostaglandins.2020.106501_bib0165","doi-asserted-by":"crossref","first-page":"35279","DOI":"10.1074\/jbc.M706762200","article-title":"A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways","volume":"282","author":"Nguyen","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"January (1)","key":"10.1016\/j.prostaglandins.2020.106501_bib0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/db06-1076","article-title":"Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity","volume":"56","author":"Lumeng","year":"2007","journal-title":"Diabetes."},{"issue":"November-December (11-12)","key":"10.1016\/j.prostaglandins.2020.106501_bib0175","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.nut.2003.08.002","article-title":"A perinatal strategy to prevent coronary heart disease","volume":"19","author":"Das","year":"2003","journal-title":"Nutrition"},{"issue":"March (3)","key":"10.1016\/j.prostaglandins.2020.106501_bib0180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0895-7061(99)00174-0","article-title":"The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats","volume":"13","author":"Higashiura","year":"2000","journal-title":"Am. J. Hypertens."},{"issue":"October (4)","key":"10.1016\/j.prostaglandins.2020.106501_bib0185","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/hy1101.092970","article-title":"Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats","volume":"38","author":"Henriksen","year":"2001","journal-title":"Hypertension."},{"issue":"February (2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.intimp.2007.07.021","article-title":"Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats","volume":"8","author":"Santos","year":"2008","journal-title":"Int. Immunopharmacol."},{"issue":"August (1-2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0195","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.physbeh.2009.05.009","article-title":"Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL\/6J mice maintained on a high fat diet","volume":"98","author":"Weisinger","year":"2009","journal-title":"Physiol. Behav."},{"issue":"February (2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ijo.2011.95","article-title":"Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL\/6J mice","volume":"36","author":"Premaratna","year":"2012","journal-title":"Int. J. Obes."},{"issue":"August (2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0205","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.00919","article-title":"Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice","volume":"62","author":"Feltenberger","year":"2013","journal-title":"Hypertension."},{"issue":"August","key":"10.1016\/j.prostaglandins.2020.106501_bib0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.peptides.2013.05.010","article-title":"Oral Angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin\/TLR4\/MAPK\/NF-kappaB in rats fed with high-fat diet","volume":"46","author":"Santos","year":"2013","journal-title":"Peptides."},{"issue":"February (1)","key":"10.1016\/j.prostaglandins.2020.106501_bib0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/15748847112079990050","article-title":"The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders","volume":"9","author":"Santos","year":"2014","journal-title":"Curr. Clin. Pharmacol."},{"issue":"October (2)","key":"10.1016\/j.prostaglandins.2020.106501_bib0220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.peptides.2012.08.002","article-title":"Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7)","volume":"37","author":"Bilman","year":"2012","journal-title":"Peptides."},{"issue":"January (1)","key":"10.1016\/j.prostaglandins.2020.106501_bib0225","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.peptides.2011.11.014","article-title":"Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes","volume":"33","author":"Mario","year":"2012","journal-title":"Peptides."},{"issue":"December","key":"10.1016\/j.prostaglandins.2020.106501_bib0230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.peptides.2014.10.005","article-title":"The role of renin-angiotensin system modulation on treatment and prevention of liver diseases","volume":"62","author":"Moreira de Macedo","year":"2014","journal-title":"Peptides."},{"issue":"March (1)","key":"10.1016\/j.prostaglandins.2020.106501_bib0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"October (39)","key":"10.1016\/j.prostaglandins.2020.106501_bib0240","doi-asserted-by":"crossref","first-page":"14219","DOI":"10.3748\/wjg.v20.i39.14219","article-title":"Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?","volume":"20","author":"Baran","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"April (5)","key":"10.1016\/j.prostaglandins.2020.106501_bib0245","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology."},{"issue":"May (5)","key":"10.1016\/j.prostaglandins.2020.106501_bib0250","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome--a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1016\/j.prostaglandins.2020.106501_bib0255","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.2147\/DDDT.S64877","article-title":"Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options","volume":"9","author":"Milic","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"September (11)","key":"10.1016\/j.prostaglandins.2020.106501_bib0260","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/01.CIR.0000141736.76561.78","article-title":"Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome","volume":"110","author":"Prasad","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2020.106501_bib0265","doi-asserted-by":"crossref","first-page":"732870","DOI":"10.1155\/2015\/732870","article-title":"Treatment of nonalcoholic steatohepatitis in adults: present and future","volume":"2015","author":"Gitto","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"issue":"August (1)","key":"10.1016\/j.prostaglandins.2020.106501_bib0270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0006-291X(03)01357-3","article-title":"AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4)","volume":"308","author":"Kanno","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"June (6)","key":"10.1016\/j.prostaglandins.2020.106501_bib0275","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/db11-0390","article-title":"Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver","volume":"61","author":"Milanski","year":"2012","journal-title":"Diabetes"},{"issue":"April (7)","key":"10.1016\/j.prostaglandins.2020.106501_bib0280","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20080253","article-title":"Metabolic disturbances in non-alcoholic fatty liver disease","volume":"116","author":"Byrne","year":"2009","journal-title":"Clin. Sci."},{"issue":"October (10)","key":"10.1016\/j.prostaglandins.2020.106501_bib0285","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"Bindom","year":"2010","journal-title":"Diabetes"},{"issue":"January (1)","key":"10.1016\/j.prostaglandins.2020.106501_bib0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2337\/db12-0177","article-title":"Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice","volume":"62","author":"Takeda","year":"2013","journal-title":"Diabetes"},{"issue":"September (5)","key":"10.1016\/j.prostaglandins.2020.106501_bib0295","first-page":"1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"November (11)","key":"10.1016\/j.prostaglandins.2020.106501_bib0300","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"issue":"December (11)","key":"10.1016\/j.prostaglandins.2020.106501_bib0305","article-title":"Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice","volume":"305","author":"Silva","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Compar. Physiol."},{"issue":"November (46)","key":"10.1016\/j.prostaglandins.2020.106501_bib0310","doi-asserted-by":"crossref","first-page":"38689","DOI":"10.1074\/jbc.M503486200","article-title":"Metabolic response of mice to a postnatal ablation of CCAAT\/enhancer-binding protein alpha","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"October (10)","key":"10.1016\/j.prostaglandins.2020.106501_bib0315","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1128\/MCB.17.10.6014","article-title":"Disruption of the c\/ebp alpha gene in adult mouse liver","volume":"17","author":"Lee","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"August (5227)","key":"10.1016\/j.prostaglandins.2020.106501_bib0320","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.7652557","article-title":"Impaired energy homeostasis in C\/EBP alpha knockout mice","volume":"269","author":"Wang","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2020.106501_bib0325","first-page":"6","article-title":"Species differences in the pharmacokinetic parameters of cytochrome P450 probe substrates between experimental animals, such as mice, rats, dogs, monkeys, and microminipigs, and humans","volume":"5","author":"Sakai","year":"2014","journal-title":"Drug Metab. Toxicol."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882320300940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882320300940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:54:37Z","timestamp":1762365277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882320300940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":65,"alternative-id":["S1098882320300940"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106501","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enalapril improves obesity associated liver injury ameliorating systemic metabolic markers by modulating Angiotensin Converting Enzymes ACE\/ACE2 expression in high-fat feed mice","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106501"}}